Self-Supervised Constraint-Induced Movement Therapy for Stroke Recovery
for Stroke
1 location in Columbus
Sponsor: Ohio State University
Sex: All·Age: 18 - 85
Code: NCT07723300·Recruiting·Listed Jul 23, 2026
Clinical Trials at Ohio State University
As of July 2026, 112 paid clinical trials are recruiting at Ohio State University, located at 1392 HIGH ST, COLUMBUS, OH 43220, phone (614) 355-9000 in Columbus, Ohio. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Ovarian Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Columbus
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
VisionWay Accessibility
for Persons With Visual Disabilities
Sites in Columbus +1 more location
Sponsor: Ohio State University
Sex: All·Age: 18+
Code: NCT07713979·Recruiting·Listed Jul 20, 2026
114 clinical trials at Ohio State University
·Clear filters·An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Columbus, Marion +110 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for Squamous Cell Carcinoma of Head and Neck
Drug: Amivantamab
Sites in Columbus, Cincinnati +43 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07276399·Phase 3·Recruiting·Listed Dec 2025
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for Alzheimers Disease
Sites in Columbus +67 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07177352·Phase 3·Recruiting·Listed Sep 2025
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for Alzheimers Disease
Drug: Trontinemab
Sites in Columbus +34 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07169578·Phase 3·Recruiting·Listed Sep 2025
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for Urothelial Carcinoma
Sites in Columbus, Cleveland +141 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT04879329·Phase 2·Recruiting·Listed May 2021
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for Acute Myeloid Leukemia (AML)
Sites in Columbus +41 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07007312·Phase 3·Recruiting·Listed Jun 2025
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for Non-Small Cell Lung Cancer
Drug: Divarasib
Sites in Columbus +49 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
for Alzheimer Disease
Drug: KarXT
Sites in Columbus, Dayton +47 more locations
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 55 - 90
Code: NCT06585787·Phase 3·Recruiting·Listed Sep 2024
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Sites in Columbus, Beavercreek +68 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06588855·Phase 3·Recruiting·Listed Sep 2024
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for Macular Edema Secondary to Inflammation
Sites in Columbus, Cleveland +51 more locations
Sponsor: Kodiak Sciences Inc
Sex: All·Age: 18+
Code: NCT06996080·Phase 3·Recruiting·Listed May 2025
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for Macular Edema Secondary to Inflammation
Sites in Columbus, Cleveland +51 more locations
Sponsor: Kodiak Sciences Inc
Sex: All·Age: 18+
Code: NCT06990399·Phase 3·Recruiting·Listed May 2025
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for Alzheimer's Disease
Drug: KarXT
Sites in Columbus, Dayton +23 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 60 - 85
Code: NCT06976216·Phase 3·Recruiting·Listed May 2025
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
Sites in Columbus +22 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
for Melanoma, Cutaneous Malignant
Sites in Columbus, Cleveland +35 more locations
Sponsor: Immatics US, Inc.
Sex: All·Age: 18+
Code: NCT06743126·Phase 3·Recruiting·Listed Dec 2024
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
for Head and Neck Squamous Cell Carcinoma
Sites in Columbus, Cincinnati +27 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06163534·Recruiting·Listed Dec 2023
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
for AMD
Sites in Columbus, Cincinnati +63 more locations
Sponsor: AbbVie
Sex: All·Age: 50 - 89
Code: NCT05407636·Phase 3·Recruiting·Listed Jun 2022
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
for Parkinson's Disease
Sites in Columbus +17 more locations
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT02071134·Recruiting·Listed Feb 2014
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
for Non-cystic Fibrosis Bronchiectasis
Sites in Columbus +27 more locations
Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Sex: All·Age: 18 - 80
Code: NCT06559150·Phase 2·Recruiting·Listed Aug 2024
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for Graft-versus-host Disease (GVHD)
Drug: Ruxolitinib
Sites in Columbus, Cleveland +28 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06615050·Phase 3·Recruiting·Listed Sep 2024
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for Myelofibrosis
Sites in Columbus +29 more locations
Sponsor: Sumitomo Pharma America, Inc.
Sex: All·Age: 18+
Code: NCT04176198·Phase 1, Phase 2·Recruiting·Listed Nov 2019
GEMINI-NSCLC: NSCLC Biomarker Study
for Non-Small Cell Lung Cancer
Sites in Columbus, Cincinnati +54 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT05236114·Recruiting·Listed Feb 2022
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for Gastrointestinal Stromal Tumor (GIST)
Sites in Columbus +31 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06655246·Phase 1·Recruiting·Listed Oct 2024
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
for IgA Nephropathy
Sites in Columbus +36 more locations
Sponsor: Calliditas Therapeutics AB
Sex: All·Age: 18+
Code: NCT06712407·Phase 4·Recruiting·Listed Dec 2024
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for Myeloproliferative Neoplasms
Drug: INCA036978
Sites in Columbus, Cleveland +21 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07441694·Phase 1·Recruiting·Listed Mar 2026
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
for Clinical High Risk for Psychosis (CHR)
Sites in Columbus +14 more locations
Sponsor: Monument Therapeutics Limited
Sex: All·Age: 17 - 30
Code: NCT07226895·Phase 1, Phase 2·Recruiting·Listed Nov 2025
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
for Glioblastoma
Sites in Columbus +10 more locations
Sponsor: Alpheus Medical, Inc.
Sex: All·Age: 18 - 80
Code: NCT07225621·Phase 2·Recruiting·Listed Nov 2025
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
for Advanced/Metastatic Solid Tumors
Sites in Columbus, Maumee +24 more locations
Sponsor: Merus B.V.
Sex: All·Age: 18+
Code: NCT03526835·Phase 1, Phase 2·Recruiting·Listed May 2018
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
for Mesial Temporal Lobe Epilepsy
Sites in Columbus, Cleveland +15 more locations
Sponsor: UniQure Biopharma B.V.
Sex: All·Age: 18 - 75
Code: NCT06063850·Phase 1, Phase 2·Recruiting·Listed Oct 2023
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for Small Cell Lung Cancer Metastatic or Locally Advanced
Sites in Columbus +19 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT07080242·Phase 1·Recruiting·Listed Jul 2025
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
for Metastatic Melanoma
Drug: Lifileucel
Sites in Columbus, Cincinnati +16 more locations
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All·Age: 18 - 70
Code: NCT05727904·Phase 3·Recruiting·Listed Feb 2023
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
for Pulmonary Arterial Hypertension (PAH)
Sites in Columbus +9 more locations
Sponsor: AllRock Bio, Inc.
Sex: All·Age: 18+
Code: NCT07175038·Phase 2·Recruiting·Listed Sep 2025
RevCore for In Stent Thrombosis
for In-stent Thrombosis
Sites in Columbus, Cleveland +14 more locations
Sponsor: Inari Medical
Sex: All·Age: 18+
Code: NCT06394739·Recruiting·Listed May 2024
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for Head and Neck Squamous Cell Carcinoma (HNSCC)
Drug: Cemiplimab
Sites in Columbus +13 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06769698·Phase 2·Recruiting·Listed Jan 2025
Lead-212 PSV359 Therapy for Patients With Solid Tumors
for Pancreatic Ductal Adenocarcinoma
Sites in Columbus +10 more locations
Sponsor: Perspective Therapeutics
Sex: All·Age: 18 - 90
Code: NCT06710756·Phase 1, Phase 2·Recruiting·Listed Nov 2024
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Columbus +22 more locations
Sponsor: Syncromune, Inc.
Sex: Male·Age: 18+
Code: NCT06533644·Phase 2·Recruiting·Listed Aug 2024
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for Solid Tumors With HRAS Alterations
Sites in Columbus +21 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06026410·Phase 1·Recruiting·Listed Sep 2023
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
for Small Cell Lung Cancer
Sites in Columbus, Cincinnati +5 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT05257551·Recruiting·Listed Feb 2022
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
for Coagulation Disorder
Sites in Columbus, Cleveland +11 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT05156983·Phase 3·Recruiting·Listed Dec 2021
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for Familial Adenomatous Polyposis (FAP)
Sites in Columbus, Cleveland +16 more locations
Sponsor: Rapamycin Holdings Inc.
Sex: All·Age: 18+
Code: NCT06950385·Phase 3·Recruiting·Listed Apr 2025
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for Neuroendocrine Tumors Unresectable
Sites in Columbus, Cleveland +17 more locations
Sponsor: Perspective Therapeutics
Sex: All·Age: 18 - 90
Code: NCT05636618·Phase 1, Phase 2·Recruiting·Listed Dec 2022
Common conditions studied in Columbus
- Acute Myeloid Leukemia (20 active studies)
- Breast Cancer (19 active studies)
- Ovarian Cancer (18 active studies)
- Chronic Lymphocytic Leukemia (17 active studies)
- Endometrial Cancer (16 active studies)
- Stage IV Lung Cancer AJCC v8 (15 active studies)
Leading research sponsors in Columbus
- Ohio State University
- Ohio State University Comprehensive Cancer Center
- National Cancer Institute (NCI)
- Nationwide Children's Hospital
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Columbus?
There are approximately 1,360 recruiting clinical trials in Columbus, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Columbus pay participants?
Most recruiting trials in Columbus compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Columbus?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Columbus?
The most common conditions under active study in Columbus include Acute Myeloid Leukemia (20), Breast Cancer (19), Ovarian Cancer (18), Chronic Lymphocytic Leukemia (17), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Columbus?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Columbus on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Columbus?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Columbus?
Recruiting research sites in Columbus include Ohio State University Comprehensive Cancer Center, Nationwide Children's Hospital, The Ohio State University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Columbus right now?
The largest active categories in Columbus are Cancer & tumors (488), Cardiovascular (76), Neurology & pain (66). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Ohio State University?
Ohio State University is located at 1392 HIGH ST, COLUMBUS, OH 43220. Use the Google Maps link in the intro above to get directions.
How do I contact Ohio State University?
You can reach Ohio State University by phone at (614) 355-9000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Ohio
Cleveland, OH(1,265)Cincinnati, OH(1,079)Dayton, OH(173)Canton, OH(146)Akron, OH(122)Toledo, OH(121)Centerville, OH(79)West Chester, OH(57)Mayfield Heights, OH(52)Franklin, OH(50)Westlake, OH(50)Beachwood, OH(49)Greenville, OH(49)Mentor, OH(48)Troy, OH(47)Dublin, OH(41)Maumee, OH(40)Kettering, OH(39)Sylvania, OH(38)Marion, OH(35)Westerville, OH(34)Beavercreek, OH(30)Zanesville, OH(30)Avon, OH(28)Lima, OH(27)Mansfield, OH(27)Middleburg Heights, OH(27)Springfield, OH(27)Youngstown, OH(26)Boardman, OH(25)Newark, OH(24)Perrysburg, OH(24)Athens, OH(23)Chillicothe, OH(23)Delaware, OH(23)Independence, OH(23)Belpre, OH(22)Fairborn, OH(20)Mount Vernon, OH(20)Portsmouth, OH(20)Gahanna, OH(19)Grove City, OH(18)Marietta, OH(18)Marysville, OH(18)North Canton, OH(18)Findlay, OH(17)Sandusky, OH(17)Hilliard, OH(16)Mason, OH(16)Pickerington, OH(16)Chardon, OH(15)Lancaster, OH(15)New Albany, OH(15)Parma, OH(14)Wooster, OH(14)Warren, OH(13)Springboro, OH(12)Blue Ash, OH(9)Fairfield, OH(9)Liberty Township, OH(9)